Case Report
Acute Hepatitis C in a Patient Receiving Etanercept
Hepatitis C aguda en un paciente en tratamiento con etanercept
Leído
6885
Vecesse ha leído el artículo
2277
Total PDF
4608
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 65 | 19 | 84 |
| 2025 5 | 123 | 34 | 157 |
| 2025 4 | 108 | 21 | 129 |
| 2025 3 | 103 | 23 | 126 |
| 2025 2 | 115 | 22 | 137 |
| 2025 1 | 71 | 32 | 103 |
| 2024 12 | 78 | 23 | 101 |
| 2024 11 | 91 | 41 | 132 |
| 2024 10 | 64 | 34 | 98 |
| 2024 9 | 65 | 22 | 87 |
| 2024 8 | 89 | 61 | 150 |
| 2024 7 | 50 | 26 | 76 |
| 2024 6 | 71 | 34 | 105 |
| 2024 5 | 59 | 30 | 89 |
| 2024 4 | 57 | 23 | 80 |
| 2024 3 | 56 | 32 | 88 |
| 2024 2 | 43 | 28 | 71 |
| 2024 1 | 43 | 35 | 78 |
| 2023 12 | 47 | 18 | 65 |
| 2023 11 | 52 | 24 | 76 |
| 2023 10 | 64 | 23 | 87 |
| 2023 9 | 55 | 31 | 86 |
| 2023 8 | 37 | 11 | 48 |
| 2023 7 | 28 | 40 | 68 |
| 2023 6 | 49 | 20 | 69 |
| 2023 5 | 40 | 20 | 60 |
| 2023 4 | 37 | 18 | 55 |
| 2023 3 | 35 | 19 | 54 |
| 2023 2 | 42 | 17 | 59 |
| 2022 1 | 25 | 27 | 52 |
| 2022 12 | 39 | 46 | 85 |
| 2022 11 | 18 | 29 | 47 |
| 2022 10 | 24 | 22 | 46 |
| 2022 9 | 22 | 36 | 58 |
| 2022 8 | 19 | 35 | 54 |
| 2022 7 | 25 | 32 | 57 |
| 2022 6 | 22 | 26 | 48 |
| 2022 5 | 35 | 31 | 66 |
| 2022 4 | 36 | 30 | 66 |
| 2022 3 | 42 | 43 | 85 |
| 2022 2 | 33 | 22 | 55 |
| 2021 1 | 32 | 35 | 67 |
| 2021 12 | 24 | 39 | 63 |
| 2021 11 | 38 | 35 | 73 |
| 2021 10 | 33 | 50 | 83 |
| 2021 9 | 29 | 41 | 70 |
| 2021 8 | 27 | 26 | 53 |
| 2021 7 | 29 | 35 | 64 |
| 2021 6 | 24 | 37 | 61 |
| 2021 5 | 28 | 24 | 52 |
| 2021 4 | 40 | 71 | 111 |
| 2021 3 | 67 | 31 | 98 |
| 2021 2 | 45 | 35 | 80 |
| 2020 1 | 37 | 19 | 56 |
| 2020 12 | 28 | 11 | 39 |
| 2020 11 | 21 | 22 | 43 |
| 2020 10 | 23 | 14 | 37 |
| 2020 9 | 28 | 11 | 39 |
| 2020 8 | 28 | 16 | 44 |
| 2020 7 | 25 | 13 | 38 |
| 2020 6 | 42 | 18 | 60 |
| 2020 5 | 43 | 11 | 54 |
| 2020 4 | 42 | 18 | 60 |
| 2020 3 | 39 | 14 | 53 |
| 2020 2 | 5 | 0 | 5 |
| 2020 1 | 4 | 2 | 6 |
| 2019 12 | 8 | 5 | 13 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 5 | 1 | 6 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 5 | 12 | 17 |
| 2019 5 | 6 | 25 | 31 |
| 2019 4 | 2 | 1 | 3 |
| 2019 3 | 4 | 11 | 15 |
| 2019 2 | 0 | 1 | 1 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 1 | 0 | 1 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 2 | 0 | 2 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 33 | 4 | 37 |
| 2018 1 | 38 | 10 | 48 |
| 2017 12 | 33 | 5 | 38 |
| 2017 11 | 33 | 4 | 37 |
| 2017 10 | 38 | 4 | 42 |
| 2017 9 | 50 | 5 | 55 |
| 2017 8 | 77 | 5 | 82 |
| 2017 7 | 63 | 4 | 67 |
| 2017 6 | 77 | 6 | 83 |
| 2017 5 | 65 | 7 | 72 |
| 2017 4 | 50 | 7 | 57 |
| 2017 3 | 34 | 1 | 35 |
| 2017 2 | 33 | 12 | 45 |
| 2016 1 | 27 | 8 | 35 |
| 2016 12 | 36 | 4 | 40 |
| 2016 11 | 44 | 7 | 51 |
| 2016 10 | 67 | 18 | 85 |
| 2016 9 | 62 | 10 | 72 |
| 2016 8 | 52 | 7 | 59 |
| 2016 7 | 29 | 6 | 35 |
| 2016 6 | 11 | 0 | 11 |
| 2016 5 | 5 | 6 | 11 |
| 2016 4 | 13 | 1 | 14 |
| 2016 3 | 4 | 1 | 5 |
| 2016 2 | 13 | 1 | 14 |
| 2015 1 | 8 | 1 | 9 |
| 2015 12 | 5 | 0 | 5 |
| 2015 11 | 11 | 1 | 12 |
| 2015 10 | 7 | 3 | 10 |
| 2015 9 | 5 | 1 | 6 |
| 2015 8 | 20 | 5 | 25 |
| 2015 7 | 64 | 114 | 178 |
| 2015 6 | 51 | 12 | 63 |
| 2015 5 | 61 | 9 | 70 |
| 2015 4 | 45 | 8 | 53 |
| 2015 3 | 8 | 5 | 13 |
| 2015 2 | 14 | 2 | 16 |
| 2015 1 | 10 | 1 | 11 |
| 2014 12 | 14 | 5 | 19 |
| 2014 11 | 5 | 5 | 10 |
| 2014 10 | 16 | 9 | 25 |
| 2014 9 | 10 | 5 | 15 |
| 2014 8 | 9 | 7 | 16 |
| 2014 7 | 7 | 5 | 12 |
| 2014 6 | 19 | 5 | 24 |
| 2014 5 | 21 | 7 | 28 |
| 2014 4 | 24 | 5 | 29 |
| 2014 3 | 25 | 6 | 31 |
| 2014 2 | 38 | 9 | 47 |
| 2014 1 | 19 | 8 | 27 |
| 2013 12 | 31 | 10 | 41 |
| 2013 11 | 18 | 7 | 25 |
| 2013 10 | 14 | 2 | 16 |
| 2013 9 | 12 | 3 | 15 |
| 2013 8 | 8 | 8 | 16 |
| 2013 7 | 4 | 8 | 12 |
| 2013 6 | 2 | 4 | 6 |
| 2013 5 | 2 | 3 | 5 |
| 2013 4 | 3 | 6 | 9 |
Mostrar todo
